| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18803951 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 103 journal articles in the PubMed database | Email to a friend | | |
| Borra R, Lautamäki R, Parkkola R, et al.
Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus. [Journal Article]
Metabolism 2008 Oct; 57(10):1445-51.
Abstract | Full Citation | Find Related Articles | | Iozzo P, Hallsten K, Oikonen V, et al.
Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes. [Journal Article]
Diabetes Care 2003 Jul; 26(7):2069-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Virtanen KA, Hällsten K, Parkkola R, et al.
Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. [Clinical Trial, Controlled Clinical Trial, Journal Article]
Diabetes 2003 Feb; 52(2):283-90.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hällsten K, Virtanen KA, Lönnqvist F, et al.
Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Diabet Med 2004 Dec; 21(12):1280-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tiikkainen M, Häkkinen AM, Korsheninnikova E, et al.
Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Diabetes 2004 Aug; 53(8):2169-76.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lautamäki R, Airaksinen KE, Seppänen M, et al.
Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Diabetes 2005 Sep; 54(9):2787-94.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Iozzo P, Hallsten K, Oikonen V, et al.
Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control. [Journal Article]
J Clin Endocrinol Metab 2003 May; 88(5):2055-60.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Viljanen AP, Virtanen KA, Järvisalo MJ, et al.
Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin. [Journal Article, Randomized Controlled Trial]
J Clin Endocrinol Metab 2005 Dec; 90(12):6523-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Juurinen L, Kotronen A, Granér M, et al.
Rosiglitazone Reduces Liver Fat and Insulin Requirements While Improving Hepatic Insulin Sensitivity And Glycemic Control In Patients With Type 2 Diabetes Requiring High Insulin Doses. [JOURNAL ARTICLE]
J Clin Endocrinol Metab 2007 Oct 23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
